Zydus Lifesciences Board Meeting on Nov 4 to Approve Q2 FY27 Results

Zydus Lifesciences Ltd has announced that its Board of Directors will convene on Wednesday, November 4, 2026. The primary agenda item for this meeting is the consideration and approval of the unaudited financial results for the quarter and half-year ended September 30, 2026. In compliance with SEBI regulations, the company has also informed about a trading window closure for directors and designated persons, which will be in effect until November 6, 2026, reopening on November 9, 2026.